Corrigendum: Loss of TARBP2 Drives the Progression of Hepatocellular Carcinoma via miR-145-SERPINE1 Axis (Frontiers in Oncology, (2021), 11, (620912), 10.3389/fonc.2021.620912)

Li Man Li, Chang Chen, Ruo Xi Ran, Jing Tao Huang, Hui Lung Sun, Chang Zeng, Zhou Zhang, Wei Zhang*, Song Mei Liu*

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations

Abstract

In the original article, there were mistakes in Figure 5 and Figure 7 as published. In Figure 5A and Figure 7A, CTL should be sh-Ctrl to keep consistence of the abbreviation throughout of the manuscript. In Figure 5B, a layer was not removed due to our less carefulness during PS operation. The corrected Figures appear below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated. (Figure presented.).

Original languageEnglish (US)
Article number746958
JournalFrontiers in Oncology
Volume11
DOIs
StatePublished - Sep 7 2021

Keywords

  • HCC
  • SERPINE1
  • TARBP2
  • miR-145
  • progression

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Corrigendum: Loss of TARBP2 Drives the Progression of Hepatocellular Carcinoma via miR-145-SERPINE1 Axis (Frontiers in Oncology, (2021), 11, (620912), 10.3389/fonc.2021.620912)'. Together they form a unique fingerprint.

Cite this